Index Option Calls
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Index Option Calls
No Result
View All Result
Home Latest News

Stocks making the biggest moves premarket: Exxon Mobil, Pfizer, Peloton and others

by
December 31, 2021
in Latest News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Dow rises for a fifth straight day, S&P 500 and Nasdaq on pace to snap 7-week losing streaks

3 takeaways from Dollar General, Dollar Tree earnings that sent stocks soaring

In this article

CFX

PTON

PFE

AMD

XOM

XLNX

Check out the companies making headlines before the bell:

Exxon Mobil (XOM) – The energy giant signaled that it will report a fourth consecutive quarterly profit, thanks in large part to stronger oil and gas prices. The snapshot of fourth quarter results came in an SEC filing, ahead of the official earnings on February 1.

Advanced Micro Devices (AMD) – The chipmaker said it now expects to complete a $35 billion all-stock takeover deal for rival Xilinx (XLNX) during the first quarter of 2022, delayed from its prior 2021 year-end target. The companies said they have not yet received all of the needed approvals. Xilinx was down 2.2% in the premarket.

Pfizer (PFE) – British regulators have approved the use of Paxlovid – the drug maker’s Covid-19 antiviral pill – for people over 18 with mild to moderate illness.

Peloton (PTON) – The fitness equipment maker slid 1.3% in premarket action after JMP Securities downgraded the stock to “market perform” from “market outperform.” JMP cites declining website visits and page views.

Colfax (CFX) – The medical technology company is planning a shareholder meeting to approve a reverse stock split, with the exact ratio to be determined at a later date. Colfax fell 2.7% in premarket trading.

MP Materials (MP) – The maker of rare earth materials filed a shelf offering of up to $2 billion in debt securities. MP shares lost 1.1% in the premarket.

Lexicon Pharmaceuticals (LXRX) – The drug maker’s shares surged 6.5% in premarket trading after it submitted a new drug application to the FDA for its heart drug sotagliflozin, which is designed to reduce the risk of heart failure in diabetic patients.

ShareTweetPin

Related Posts

Dow rises for a fifth straight day, S&P 500 and Nasdaq on pace to snap 7-week losing streaks

by
May 26, 2022
0

Stocks rose Thursday, as Wall Street tried to rebound from a long string of weekly declines. The Dow rose 511...

3 takeaways from Dollar General, Dollar Tree earnings that sent stocks soaring

by
May 26, 2022
0

In this article DLTR DG Dollar General and Dollar Tree stores Getty Images Shares of Dollar General and Dollar Tree...

Earnings reports are causing big moves for stocks. Here’s a way to play them with options

by
May 26, 2022
0

A volatile earnings season is winding down, but there are still a few opportunities for investors to take advantage of...

Goldman says it’s time to be a stock picker with energy stocks. Here are the firm’s favorites

by
May 26, 2022
0

Energy stocks are outperforming this week, month and year, and Goldman Sachs believes that while there's still value to be...

Microsoft exec tells employees in Windows and Office groups to be more cautious in hiring

by
May 26, 2022
0

Satya Nadella, chief executive officer of Microsoft Corp., appears at a panel session at the World Economic Forum in Davos,...

Next Post

Stock futures dip ahead of the final trading session of 2021

Furniture giant IKEA raises prices as supply chain woes persist

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • A Couple Stored IRA Gold at Home. They Owe the IRS More Than $300,000.

    0 shares
    Share 0 Tweet 0
  • A California Couple Spent Eight Years Building Their Dream Retirement Home in Costa Rica

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs says buy these stocks to play Web 3.0 and the metaverse

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs picks new stocks to buy — and says these 5 have over 100% upside

    0 shares
    Share 0 Tweet 0
  • In his final warning, this stock trading wizard — who made big money in bear markets and crashes — called this market a bubble like no other

    0 shares
    Share 0 Tweet 0
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.indexoptioncalls.com
No Result
View All Result
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.indexoptioncalls.com